Trial Identifier: | D8990C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05797168 |
Start Date: | June 2023 |
Primary Completion Date: | November 2027 |
Study Completion Date: | November 2027 |
Condition: | Ovarian Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
AU | Melbourne, AU, 3000 |
US, CA | Duarte, CA, US, 91010 |
US, CA | La Jolla, CA, US, 92093 |
US, KY | Louisville, KY, US, 40202 |
US, MA | Boston, MA, US, 02114 |
US, OH | Columbus, OH, US, 43201 |
US, OR | Portland, OR, US, 97239 |
US, TX | Houston, TX, US, 77030 |